Non-invasive assessment and therapeutic targeting in metabolic dysfunction-associated steatohepatitis (MASH) : overcoming the dissonance between drug development and precision medicine
Source
Drugs - ISSN 0012-6667- (2026) p.
Plasma cell-free transcriptome profiling in blood plasma from chronic liver disease patients
Source
Scientific Data - ISSN 2052-4463-13:1 (2026) p.
Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis : a phase 2, dose-ranging, double-blind, randomised controlled trial
Source
Lancet gastroenterology & hepatology - ISSN 2468-1253-11:9 (2026) p. 797-811
Hepatology : emerging paradigms in MASLD, viral hepatitis, cholestatic liver disease, portal hypertension and hepatocellular carcinoma
Source
Liver international - ISSN 1478-3223-46:9 (2026) p.
Delphi survey to explore core curriculum for training the next generation of hepatologists
Source
JHEP Reports - ISSN 2589-5559-8:9 (2026) p.